Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars

Phase 4 Study of Scarclinic™ Thin That Treats Surgical Scars.

NCT01689857•Seoul National University Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Hypertrophic Surgical Scar

Interventions

Scarclinic™ Thin

Scarclinic™ Normal

Locations

South Korea

Locations (1)

Seoul National Univ. Bundang Hospital

Bundang-gu, Seongnam-si,Gyeonggi-do, South Korea

Key Dates

Start Date

October 1, 2010

Primary Completion Date

July 1, 2012

Completion Date

August 1, 2012

Last Updated

April 15, 2013

Sponsors

Lead Sponsor

Seoul National University Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 15, 2013Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions